DK2830662T3 - Fremgangsmåder til behandlng af hårtabsforstyrrelser - Google Patents
Fremgangsmåder til behandlng af hårtabsforstyrrelser Download PDFInfo
- Publication number
- DK2830662T3 DK2830662T3 DK13769804.9T DK13769804T DK2830662T3 DK 2830662 T3 DK2830662 T3 DK 2830662T3 DK 13769804 T DK13769804 T DK 13769804T DK 2830662 T3 DK2830662 T3 DK 2830662T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- methods
- hair loss
- loss disorders
- disorders
- Prior art date
Links
- 201000004384 Alopecia Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000024963 hair loss Diseases 0.000 title 1
- 230000003676 hair loss Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261617225P | 2012-03-29 | 2012-03-29 | |
| US201261645499P | 2012-05-10 | 2012-05-10 | |
| PCT/US2013/034688 WO2013149194A1 (en) | 2012-03-29 | 2013-03-29 | Methods for treating hair loss disorders |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2830662T3 true DK2830662T3 (da) | 2019-01-02 |
Family
ID=49261311
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK13769804.9T DK2830662T3 (da) | 2012-03-29 | 2013-03-29 | Fremgangsmåder til behandlng af hårtabsforstyrrelser |
Country Status (12)
| Country | Link |
|---|---|
| EP (2) | EP3459565A1 (da) |
| JP (2) | JP6212107B2 (da) |
| KR (1) | KR102135601B1 (da) |
| CN (1) | CN104334191A (da) |
| DK (1) | DK2830662T3 (da) |
| ES (1) | ES2694681T3 (da) |
| HR (1) | HRP20181976T1 (da) |
| HU (1) | HUE040127T2 (da) |
| PL (1) | PL2830662T3 (da) |
| PT (1) | PT2830662T (da) |
| SI (1) | SI2830662T1 (da) |
| WO (1) | WO2013149194A1 (da) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20180002838A (ko) * | 2015-05-07 | 2018-01-08 | 더 트러스티스 오브 콜롬비아 유니버시티 인 더 시티 오브 뉴욕 | 모발 생장을 촉진하기 위한 방법 및 조성물 |
| CN104789689B (zh) * | 2015-05-13 | 2018-10-02 | 北京泱深生物信息技术有限公司 | 作为肺腺癌诊治靶标的clec9a基因 |
| JP6767491B2 (ja) | 2015-09-25 | 2020-10-14 | ディザル（ジァンスー）ファーマシューティカル・カンパニー・リミテッド | Ｊａｋを阻害するための化合物及び方法 |
| KR20170101724A (ko) * | 2016-02-29 | 2017-09-06 | 양지화학 주식회사 | 야누스인산화효소 억제제로서의 치환된 N-(피롤리딘-3-일)-7H-피롤로[2,3-d]피리미딘-4-아민의 용도 |
| CN105695617A (zh) * | 2016-04-22 | 2016-06-22 | 王冬国 | 乳头状癌的肿瘤标志物及其应用 |
| US10561659B2 (en) | 2016-05-04 | 2020-02-18 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated JAK inhibitors |
| JP7519660B2 (ja) * | 2016-06-14 | 2024-07-22 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 疾患を処置するための遺伝子改変された細胞、組織、および臓器 |
| KR101657082B1 (ko) * | 2016-08-08 | 2016-09-13 | 에스씨엠생명과학 주식회사 | CXCL1(chemokine (C-X-C motif) ligand 1) 단백질을 유효성분으로 포함하는 탈모 예방 또는 치료용 약학적 조성물 |
| AU2017358703A1 (en) * | 2016-11-10 | 2019-05-09 | Galapagos Nv | Compounds and pharmaceutical compositions thereof for the treatment of inflammatory diseases |
| AU2018312349A1 (en) | 2017-08-01 | 2020-02-06 | Theravance Biopharma R&D Ip, Llc | Pyrazolo and triazolo bicyclic compounds as JAK kinase inhibitors |
| WO2019094798A1 (en) | 2017-11-10 | 2019-05-16 | The Trustees Of Columbia University In The City Of New York | Methods and compositions for promoting or inducing hair growth |
| EP3810144A4 (en) * | 2018-06-04 | 2022-08-17 | Chemistryrx | Topical compositions for stimulating hair growth |
| WO2020154350A1 (en) | 2019-01-23 | 2020-07-30 | Theravance Biopharma R&D Ip, Llc | Imidazo[1,5-a]pyridine, 1,2,4-triazolo[4,3-a]pyridine and imidazo[1,5-a]pyrazine as jak inhibitors |
| KR102197723B1 (ko) * | 2019-03-08 | 2020-12-31 | 주식회사 네오젠티씨 | 림프구의 종양 반응성 예측용 마커 및 이의 용도 |
| CN111041095B (zh) * | 2019-07-11 | 2021-11-30 | 江苏医药职业学院 | 检测8号染色体开放阅读框73表达水平的试剂的应用和试剂盒 |
| KR102187371B1 (ko) * | 2019-08-02 | 2020-12-04 | 연세대학교 산학협력단 | FoxQ1 유전자가 과발현된 지방유래 줄기세포 및 이의 용도 |
| AU2020378151A1 (en) * | 2019-11-08 | 2022-05-26 | Cage Bio, Inc. | Topical delivery of tofacitinib using ionic liquid |
| EP4065578A1 (en) | 2019-11-26 | 2022-10-05 | Theravance Biopharma R&D IP, LLC | Fused pyrimidine pyridinone compounds as jak inhibitors |
| US12441707B2 (en) | 2019-12-30 | 2025-10-14 | Tyra Biosciences, Inc. | Indazole compounds |
| WO2021232054A1 (en) * | 2020-05-12 | 2021-11-18 | Chemistryrx | Compositions for treating hair loss |
| FR3111917B1 (fr) * | 2020-06-30 | 2025-04-11 | Oreal | Signature moléculaire d’un état alopécique commun, associée aux jonctions cellulaires |
| US20240382480A1 (en) * | 2021-04-22 | 2024-11-21 | Shenzhen Chipscreen Biosciences Co., Ltd. | Pharmaceutical composition containing jak3/jak1/tbk1 selective inhibitor and medical use thereof |
| WO2023018904A1 (en) | 2021-08-11 | 2023-02-16 | Concert Pharmaceuticals, Inc. | Treatment of hair loss disorders with deuterated jak inhibitors |
| CN116262136A (zh) * | 2021-12-13 | 2023-06-16 | 复旦大学附属华山医院 | 以脯氨酰羟化酶为靶点治疗脱发疾病的药物 |
| CN118786125A (zh) * | 2022-03-18 | 2024-10-15 | 四川科伦博泰生物医药股份有限公司 | 氮杂环丁烷衍生物的用途及治疗方法 |
| CN114870016B (zh) * | 2022-04-21 | 2023-05-26 | 上海博悦生物科技有限公司 | 一种jak抑制剂的微乳泡沫剂及其应用 |
| CN115137832B (zh) * | 2022-07-07 | 2023-11-17 | 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) | 一种jak抑制剂的用途及其抗毛霉感染实验方法 |
| FR3143040A1 (fr) * | 2022-12-12 | 2024-06-14 | L'oreal | Méthode de pronostic et/ou de diagnostic d’une perte de densité capillaire |
Family Cites Families (70)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4921475A (en) | 1983-08-18 | 1990-05-01 | Drug Delivery Systems Inc. | Transdermal drug patch with microtubes |
| US5087240A (en) | 1983-08-18 | 1992-02-11 | Drug Delivery Systems Inc. | Transdermal drug patch with conductive fibers |
| US4683202A (en) | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US4683195A (en) | 1986-01-30 | 1987-07-28 | Cetus Corporation | Process for amplifying, detecting, and/or-cloning nucleic acid sequences |
| US5163899A (en) | 1987-03-20 | 1992-11-17 | Drug Delivery Systems Inc. | Transdermal drug delivery system |
| US5312325A (en) | 1987-05-28 | 1994-05-17 | Drug Delivery Systems Inc | Pulsating transdermal drug delivery system |
| US5080891A (en) | 1987-08-03 | 1992-01-14 | Ddi Pharmaceuticals, Inc. | Conjugates of superoxide dismutase coupled to high molecular weight polyalkylene glycols |
| US5879680A (en) | 1987-12-23 | 1999-03-09 | The United States Of America As Represented By The Department Of Health And Human Services | Cloned DNA for synthesizing unique glucocerebrosidase |
| GB8804164D0 (en) | 1988-02-23 | 1988-03-23 | Tucker J M | Bandage for administering physiologically active compound |
| US5223409A (en) | 1988-09-02 | 1993-06-29 | Protein Engineering Corp. | Directed evolution of novel binding proteins |
| US5008110A (en) | 1988-11-10 | 1991-04-16 | The Procter & Gamble Company | Storage-stable transdermal patch |
| US5088977A (en) | 1988-12-21 | 1992-02-18 | Drug Delivery Systems Inc. | Electrical transdermal drug applicator with counteractor and method of drug delivery |
| US6451600B1 (en) | 1989-12-22 | 2002-09-17 | Genzyme Corporation | Enzymatically active recombinant glucocerebrosidase |
| US5236838A (en) | 1988-12-23 | 1993-08-17 | Genzyme Corporation | Enzymatically active recombinant glucocerebrosidase |
| US5096815A (en) | 1989-01-06 | 1992-03-17 | Protein Engineering Corporation | Generation and selection of novel dna-binding proteins and polypeptides |
| US5198346A (en) | 1989-01-06 | 1993-03-30 | Protein Engineering Corp. | Generation and selection of novel DNA-binding proteins and polypeptides |
| US5179023A (en) | 1989-03-24 | 1993-01-12 | Research Corporation Technologies, Inc. | Recombinant α-galactosidase a therapy for Fabry disease |
| US5328470A (en) | 1989-03-31 | 1994-07-12 | The Regents Of The University Of Michigan | Treatment of diseases by site-specific instillation of cells or site-specific transformation of cells and kits therefor |
| AU638762B2 (en) | 1989-10-05 | 1993-07-08 | Optein Inc | Cell-free synthesis and isolation of novel genes and polypeptides |
| PT96059B (pt) | 1989-12-04 | 1998-07-31 | Searle & Co | Sistema de camada unica para a administracao de um medicamento por via transdermica |
| US5747334A (en) | 1990-02-15 | 1998-05-05 | The University Of North Carolina At Chapel Hill | Random peptide library |
| US5401650A (en) | 1990-10-24 | 1995-03-28 | The Mount Sinai School Of Medicine Of The City University Of New York | Cloning and expression of biologically active α-galactosidase A |
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| EP0575518A1 (en) | 1991-03-06 | 1993-12-29 | Board Of Regents, The University Of Texas System | Methods and compositions for the selective inhibition of gene expression |
| US6410010B1 (en) | 1992-10-13 | 2002-06-25 | Board Of Regents, The University Of Texas System | Recombinant P53 adenovirus compositions |
| US5352456A (en) | 1991-10-10 | 1994-10-04 | Cygnus Therapeutic Systems | Device for administering drug transdermally which provides an initial pulse of drug |
| US5252479A (en) | 1991-11-08 | 1993-10-12 | Research Corporation Technologies, Inc. | Safe vector for gene therapy |
| DE69228827T2 (de) | 1991-12-18 | 1999-10-21 | Minnesota Mining And Mfg. Co., Saint Paul | Mehrschichtige sperrstrukturen |
| EP0553769B1 (de) | 1992-01-29 | 1996-01-03 | FRANZ VÖLKL GmbH & CO. SKI UND TENNIS SPORTARTIKELFABRIK KG | Ballspielschläger, insbesondere Tennisschläger |
| US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
| EP0740791A4 (en) | 1994-01-05 | 2000-04-05 | Arqule Inc | SYSTEMATIC MODULAR PRODUCTION OF AMINIMID AND OXAZOLONE-BASED MOLECULES WITH SELECTED PROPERTIES |
| US5705625A (en) * | 1994-12-15 | 1998-01-06 | The Johns Hopkins University School Of Medicine | Nucleic Acid Encoding novel protein tyrosine kinase |
| US5712171A (en) | 1995-01-20 | 1998-01-27 | Arqule, Inc. | Method of generating a plurality of chemical compounds in a spatially arranged array |
| DK0863984T3 (da) | 1995-11-30 | 2006-08-28 | Univ Texas | Fremgangsmåder og præparater til behandling af cancer |
| US6458574B1 (en) | 1996-09-12 | 2002-10-01 | Transkaryotic Therapies, Inc. | Treatment of a α-galactosidase a deficiency |
| US6083725A (en) | 1996-09-13 | 2000-07-04 | Transkaryotic Therapies, Inc. | Tranfected human cells expressing human α-galactosidase A protein |
| GB9623833D0 (en) | 1996-11-16 | 1997-01-08 | Zeneca Ltd | Chemical compound |
| US7419661B2 (en) | 1997-04-30 | 2008-09-02 | The Centre Of Excellence For Life Sciences Limited | Dermal sheath tissue in wound healing |
| TW589189B (en) | 1997-08-04 | 2004-06-01 | Scras | Kit containing at least one double-stranded RNA combined with at least one anti-viral agent for therapeutic use in the treatment of a viral disease, notably of viral hepatitis |
| US6210666B1 (en) | 1997-10-21 | 2001-04-03 | Orphan Medical, Inc. | Truncated α-galactosidase A to treat fabry disease |
| US6506559B1 (en) | 1997-12-23 | 2003-01-14 | Carnegie Institute Of Washington | Genetic inhibition by double-stranded RNA |
| AU4851599A (en) * | 1998-06-30 | 2000-01-17 | Parker Hughes Institute | Method for inhibiting c-jun expression using jak-3 inhibitors |
| GB9827152D0 (en) | 1998-07-03 | 1999-02-03 | Devgen Nv | Characterisation of gene function using double stranded rna inhibition |
| EP2314700A1 (en) | 1999-01-28 | 2011-04-27 | Medical College of Georgia Research Institute, Inc | Composition and method for in vivo and in vitro attenuation of gene expression using double stranded RNA |
| DE19956568A1 (de) | 1999-01-30 | 2000-08-17 | Roland Kreutzer | Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens |
| DE60017115T2 (de) * | 1999-02-10 | 2005-12-08 | Mitsubishi Pharma Corp. | Amid-derivate und deren medizinische verwendung |
| WO2001029058A1 (en) | 1999-10-15 | 2001-04-26 | University Of Massachusetts | Rna interference pathway genes as tools for targeted genetic interference |
| GB9925964D0 (en) | 1999-11-03 | 1999-12-29 | Jahoda Colin A B | Hair transplantation |
| GB9927444D0 (en) | 1999-11-19 | 2000-01-19 | Cancer Res Campaign Tech | Inhibiting gene expression |
| US6188045B1 (en) | 2000-04-03 | 2001-02-13 | Alto-Shaam, Inc. | Combination oven with three-stage water atomizer |
| US6421962B2 (en) | 2000-04-20 | 2002-07-23 | Mcnamara Bernard | Swimming pool assembly |
| US20020173478A1 (en) | 2000-11-14 | 2002-11-21 | The Trustees Of The University Of Pennsylvania | Post-transcriptional gene silencing by RNAi in mammalian cells |
| US7294504B1 (en) | 2001-12-27 | 2007-11-13 | Allele Biotechnology & Pharmaceuticals, Inc. | Methods and compositions for DNA mediated gene silencing |
| MXPA04011956A (es) * | 2002-05-30 | 2005-03-31 | Vertex Pharma | Inhibidores de proteinas cinasas jak y cdk2. |
| US7148342B2 (en) | 2002-07-24 | 2006-12-12 | The Trustees Of The University Of Pennyslvania | Compositions and methods for sirna inhibition of angiogenesis |
| CA2505409C (en) | 2002-11-14 | 2017-04-04 | Intercytex Limited | Cultivation of hair inductive cells |
| WO2004063715A2 (en) | 2003-01-10 | 2004-07-29 | The Trustees Of Columbia University In The City Of New York | Methods of using crystal structure of carboxyltransferase domain of acetyl-coa carboxylase, modulators thereof, and computer methods |
| JP2007536310A (ja) * | 2004-05-03 | 2007-12-13 | ノバルティス アクチエンゲゼルシャフト | Ｓ１ｐ受容体アゴニストおよびｊａｋ３キナーゼ阻害剤を含む、組合せ剤 |
| US8071559B2 (en) | 2005-05-02 | 2011-12-06 | Cold Spring Harbor Laboratory | Compositions and methods for cancer diagnosis and treatment |
| US20070041905A1 (en) * | 2005-08-19 | 2007-02-22 | Hoffman Rebecca S | Method of treating depression using a TNF-alpha antibody |
| AU2006315601A1 (en) | 2005-11-14 | 2007-05-24 | Enterprise Partners Venture Capital | Stem cell factor therapy for tissue injury |
| DE602006019916D1 (de) | 2005-12-12 | 2011-03-10 | Canji Inc | Adenovirale expressionsvektoren mit einer expressionskassette im e1-bereich und einer inaktivierten e2b-polymerase |
| NZ601687A (en) * | 2006-01-17 | 2014-03-28 | Vertex Pharma | Azaindoles useful as inhibitors of janus kinases |
| JP5386180B2 (ja) | 2006-02-28 | 2014-01-15 | ザ トラスティーズ オブ コロンビア ユニヴァーシティ イン ザ シティ オブ ニューヨーク | 真皮細胞のコンパクト凝集のための方法 |
| WO2007101232A2 (en) * | 2006-02-28 | 2007-09-07 | Cytopia Research Pty, Ltd. | Inhibition of jak2 as a treatment of pulmonary arterial hypertension |
| GB0605691D0 (en) * | 2006-03-21 | 2006-05-03 | Novartis Ag | Organic Compounds |
| US7704533B2 (en) * | 2006-12-13 | 2010-04-27 | J&J Consumer Companies, Inc. | Compositions and methods of inducing hair growth utilizing Continus coggygria |
| JP2011518836A (ja) * | 2008-04-24 | 2011-06-30 | インサイト・コーポレイション | 大環状化合物およびそれらのキナーゼ阻害剤としての使用 |
| US8592415B2 (en) * | 2009-02-11 | 2013-11-26 | Reaction Biology Corp. | Selective kinase inhibitors |
| CN103370076A (zh) * | 2010-11-02 | 2013-10-23 | 纽约市哥伦比亚大学托管会 | 治疗毛发脱落疾病的方法 |
-
2013
- 2013-03-29 CN CN201380027870.1A patent/CN104334191A/zh active Pending
- 2013-03-29 PL PL13769804T patent/PL2830662T3/pl unknown
- 2013-03-29 HU HUE13769804A patent/HUE040127T2/hu unknown
- 2013-03-29 SI SI201331215T patent/SI2830662T1/sl unknown
- 2013-03-29 WO PCT/US2013/034688 patent/WO2013149194A1/en not_active Ceased
- 2013-03-29 DK DK13769804.9T patent/DK2830662T3/da active
- 2013-03-29 JP JP2015503662A patent/JP6212107B2/ja active Active
- 2013-03-29 ES ES13769804.9T patent/ES2694681T3/es active Active
- 2013-03-29 EP EP18188102.0A patent/EP3459565A1/en not_active Withdrawn
- 2013-03-29 HR HRP20181976TT patent/HRP20181976T1/hr unknown
- 2013-03-29 EP EP13769804.9A patent/EP2830662B1/en active Active
- 2013-03-29 KR KR1020147030281A patent/KR102135601B1/ko active Active
- 2013-03-29 PT PT13769804T patent/PT2830662T/pt unknown
-
2017
- 2017-09-14 JP JP2017176433A patent/JP6527565B2/ja active Active
Also Published As
| Publication number | Publication date |
|---|---|
| KR20140148459A (ko) | 2014-12-31 |
| KR102135601B1 (ko) | 2020-07-20 |
| WO2013149194A1 (en) | 2013-10-03 |
| JP2018027959A (ja) | 2018-02-22 |
| JP2015515470A (ja) | 2015-05-28 |
| HRP20181976T1 (hr) | 2019-01-25 |
| EP2830662A4 (en) | 2015-09-09 |
| EP3459565A1 (en) | 2019-03-27 |
| JP6527565B2 (ja) | 2019-06-05 |
| HUE040127T2 (hu) | 2019-02-28 |
| EP2830662B1 (en) | 2018-08-29 |
| PL2830662T3 (pl) | 2019-02-28 |
| EP2830662A1 (en) | 2015-02-04 |
| PT2830662T (pt) | 2018-11-29 |
| CN104334191A (zh) | 2015-02-04 |
| JP6212107B2 (ja) | 2017-10-11 |
| ES2694681T3 (es) | 2018-12-26 |
| SI2830662T1 (sl) | 2019-01-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2830662T3 (da) | Fremgangsmåder til behandlng af hårtabsforstyrrelser | |
| DK2635299T3 (da) | Fremgangsmåder til behandling af hårtabsforstyrrelser | |
| LT2885010T (lt) | Tautopatijos gydymo būdai | |
| DK2983787T3 (da) | Fremgangsmåde til behandling af posttraumatisk stresssygdom | |
| DK2968208T3 (da) | Behandling af kataplexi | |
| DK2906696T4 (da) | Fremgangsmåder til modulering af c9orf72-ekspression | |
| DK2846809T3 (da) | Behandling af myelosuppression | |
| DK2897620T3 (da) | Fremgangsmåde til behandling af cancer | |
| DK2919796T3 (da) | Brug af akkermansia til behandling af stofskiftesygdomme | |
| DK2895156T3 (da) | Fremgangsmåde til fremstilling af terapeutiske nanopartikler | |
| DK3329884T3 (da) | Implanterbar indretning til behandling af glaukom | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| DK2701733T3 (da) | Forbindelser til behandling af neuropsykiatriske forstyrrelser | |
| SI2707029T1 (sl) | Metode zdravljenja ali preprečevanja s holesterolom povezanih motenj | |
| DK2981255T3 (da) | Terapeutiske anvendelser af empagliflozin | |
| DK3054976T3 (da) | Anvendelse af semaphorin-4d-bindende molekyler til behandling af aterosklerose | |
| DK3626270T3 (da) | Behandling af kardiovaskulære sygdomme | |
| DK2747763T3 (da) | (bacterio-)chlorofyllfotosensibilisatorer til behandling af øjensygdomme og -lidelser | |
| DK2961378T3 (da) | Fremgangsmåder til behandlingen af mitochondrisk sygdom | |
| LT3007726T (lt) | Tautopatijos gydymo būdai | |
| DK2897611T3 (da) | Fremgangsmåder til behandling af hepatitis c | |
| PL2776055T3 (pl) | Sposoby leczenia zaburzeń żołądkowo-jelitowych | |
| DK2961426T3 (da) | Behandling af sygdomme i centralnervesystemet ved intranasal indgivelse af immunoglobulin g | |
| BR112013023142A2 (pt) | método de tratamento de cabelos | |
| IL237449A0 (en) | Methods for treating health conditions related to hair |